TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) Profit Breakdown: By Geography
- 2026-06-30: United States $1.20B; Europe $704.00M; International Markets $284.00M.
- 2025-06-30: United States $1.21B; Europe $717.00M; International Markets $244.00M.
Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.
- Available history
- 2007-12-31 to 2026-06-30
- Data captured
Profit by region
Gross margin: each quarter (3 month)
| Quarter end | United States | Europe | International Markets |
|---|---|---|---|
| 2026-06-30 | $1.20B derived | $704.00M derived | $284.00M derived |
| 2025-06-30 | $1.21B derived | $717.00M derived | $244.00M derived |
Operating income: each quarter (3 month)
| Quarter end | United States | Europe | International Markets |
|---|---|---|---|
| 2026-06-30 | -$76.00M | $367.00M | $99.00M |
| 2025-06-30 | $699.00M | $364.00M | $74.00M |